Hanson & Doremus Investment Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Buy
23,092
+16,657
+259% +$397K 0.06% 125
2026
Q1
$154K Sell
6,435
-100
-2% -$2.41K 0.02% 218
2025
Q4
$158K Buy
6,535
+60
+0.9% +$1.45K 0.02% 216
2025
Q3
$156K Buy
+6,475
New +$156K 0.02% 220

Other funds holding IBD

Hanson & Doremus Investment Management's IBD Position: Q2 2026 in Review

Hanson & Doremus Investment Management increased its Inspire Corporate Bond ETF (IBD) stake by 259% in Q2 2026, buying an estimated $397K and bringing the position to 23,092 shares worth $549K. The position accounts for 0.06% of the portfolio, ranked #125.

Hanson & Doremus Investment Management first reported a position in IBD in Q3 2025 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Hanson & Doremus Investment Management held 23,092 shares of Inspire Corporate Bond ETF worth $549K as of Q2 2026.
  • Hanson & Doremus Investment Management bought 16,657 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $397K.
  • Inspire Corporate Bond ETF made up 0.06% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #125 holding.
  • Hanson & Doremus Investment Management first reported a position in Inspire Corporate Bond ETF in Q3 2025 and has held it in 4 quarters since.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.